--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--------
US Stock MarketDetailed Quotes
KYTX Kyverna Therapeutics
- 8.660
- -0.090-1.03%
Close Jul 31 16:00 ET
- 8.920
- +0.260+3.00%
Post 17:51 ET
373.38MMarket Cap-4917P/E (TTM)
9.040High8.250Low310.94KVolume8.860Open8.750Pre Close2.69MTurnover1.87%Turnover RatioLossP/E (Static)43.12MShares35.06052wk High1.03P/B144.41MFloat Cap6.75052wk Low--Dividend TTM16.68MShs Float35.060Historical High--Div YieldTTM9.03%Amplitude6.750Historical Low8.645Avg Price1Lot Size
Kyverna Therapeutics Key Stats
Kyverna Therapeutics Earnings Date
Currency: USD
Period
Q1 FY2024 Earnings
--
Revenue(YoY)
0.00
0.00%EPS(YoY)
-1.12
-159.36%Analyst Rating
Jul 31, 2024
Kyverna Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Kyverna Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
